Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Rosemarie, Krupar"'
Autor:
David Schaer, Rosemarie Krupar, Vasiliki Pelekanou, Yuko Ishii, Simon Schallenberg, Sharon Ruane, Cornelius Böhm, Lukas Ruff, Maximilian Alber, Katja Lingelbach, Blanca Pablos, Simon Heinke, Nader Aldoj, Suhas Pandhe, Luca Pizzagalli, Maximilian Gottschalk, Bartosz Wójtowicz, Stephan Tietz, Marion Rudolph, Emmanuelle di Tomaso
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ac3dd7d96b1d42fe982aad4bc2c2054c
Autor:
Christiane Kuempers, Tobias Jagomast, Rosemarie Krupar, Finn-Ole Paulsen, Carsten Heidel, Julika Ribbat-Idel, Christian Idel, Bruno Märkl, Martin Anlauf, Sabina Berezowska, Markus Tiemann, Hans Bösmüller, Falko Fend, Barbara Kalsdorf, Sabine Bohnet, Eva Dreyer, Verena Sailer, Jutta Kirfel, Sven Perner
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Rovalpituzumab tesirine (Rova-T), an antibody-drug conjugate directed against Delta-like protein 3 (DLL3), is under development for patients with small cell lung cancer (SCLC). DLL3 is expressed on the majority of SCLC samples. Because SCLC is rarely
Externí odkaz:
https://doaj.org/article/2f2a6251c4574098908108fee406f2a3
Autor:
Christian Idel, Julika Ribbat-Idel, Luise Klapper, Rosemarie Krupar, Karl-Ludwig Bruchhage, Eva Dreyer, Dirk Rades, Christina Polasky, Anne Offermann, Jutta Kirfel, Sven Perner, Barbara Wollenberg
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundHead and neck squamous cell carcinomas (HNSCCs) have a very moderate response rate to immune checkpoint inhibitor (ICI) treatment compared to other cancer types. Lacking predictive markers for treatment response, we analyzed the immune stat
Externí odkaz:
https://doaj.org/article/90f3e170be3a4df9b68b0ce402e8f27c
Autor:
Julika Ribbat-Idel, Franz F. Dressler, Rosemarie Krupar, Christian Watermann, Finn-Ole Paulsen, Patrick Kuppler, Luise Klapper, Anne Offermann, Barbara Wollenberg, Dirk Rades, Simon Laban, Markus Reischl, Karl-Ludwig Bruchhage, Christian Idel, Sven Perner
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: The approval of immune checkpoint inhibitors in combination with specific diagnostic biomarkers presents new challenges to pathologists as tumor tissue needs to be tested for expression of programmed death-ligand 1 (PD-L1) for a variety o
Externí odkaz:
https://doaj.org/article/15556fe55b95403ba64bfc0e98d5b371
Autor:
Julika Ribbat-Idel, Sven Perner, Patrick Kuppler, Luise Klapper, Rosemarie Krupar, Christian Watermann, Finn-Ole Paulsen, Anne Offermann, Karl-Ludwig Bruchhage, Barbara Wollenberg, Christian Idel
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Head and neck squamous cell carcinoma (HNSCC) represents a common cancer worldwide. Past therapeutic advances have not significantly improved HNSCC prognosis. Therefore, it is necessary to further stratify HNSCC, especially with recent ad
Externí odkaz:
https://doaj.org/article/feb464f6cd47446e8be525455f063825
Autor:
Alireza Saraji, Anne Offermann, Janine Stegmann-Frehse, Katharina Hempel, Duan Kang, Rosemarie Krupar, Christian Watermann, Danny Jonigk, Mark Philipp Kühnel, Jutta Kirfel, Sven Perner, Verena Sailer
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257416 (2021)
With the advance of precision medicine, the availability of tumor tissue for molecular analysis has become a limiting factor. This is particularly the case for bone metastases which are frequently occurring in cancer types such as prostate cancer. Du
Externí odkaz:
https://doaj.org/article/1e828c583f6242608f0c9b44085808a4
Autor:
Aurelie Hanoteau, Jared M. Newton, Rosemarie Krupar, Chen Huang, Hsuan-Chen Liu, Angelina Gaspero, Robyn D. Gartrell, Yvonne M. Saenger, Thomas D. Hart, Saskia J. Santegoets, Damya Laoui, Chad Spanos, Falguni Parikh, Padmini Jayaraman, Bing Zhang, Sjoerd H. Van der Burg, Jo A. Van Ginderachter, Cornelis J. M. Melief, Andrew G. Sikora
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-19 (2019)
Abstract Background Chemoradiotherapy (CRT) remains one of the most common cancer treatment modalities, and recent data suggest that CRT is maximally effective when there is generation of an anti-tumoral immune response. However, CRT has also been sh
Externí odkaz:
https://doaj.org/article/529ee5858b424de6b4b551d4e3d1d450
Autor:
Rosemarie Krupar
Publikováno v:
Die Pathologie. 43:141-147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1865bca2c8bb94d35fc3468e3ad18f05
https://doi.org/10.1007/s00292-022-01159-0
https://doi.org/10.1007/s00292-022-01159-0
Autor:
Padmini Jayaraman, Falguni Parikh, Jared M. Newton, Aurelie Hanoteau, Charlotte Rivas, Rosemarie Krupar, Kimal Rajapakshe, Ravi Pathak, Kavin Kanthaswamy, Cassie MacLaren, Shixia Huang, Cristian Coarfa, Chad Spanos, Dean P. Edwards, Robin Parihar, Andrew G. Sikora
Publikováno v:
OncoImmunology, Vol 7, Iss 10 (2018)
Cancer-induced myeloid-derived suppressor cells (MDSC) play an important role in tumor immune evasion. MDSC programming or polarization has been proposed as a strategy for leveraging the developmental plasticity of myeloid cells to reverse MDSC immun
Externí odkaz:
https://doaj.org/article/83f7a6009b6146aaa71b466f52fbd60c
Autor:
Ramona Erber, Steffen Spoerl, Andreas Mamilos, Rosemarie Krupar, Arndt Hartmann, Matthias Ruebner, Juergen Taxis, Mareike Wittenberg, Torsten E. Reichert, Gerrit Spanier, Silvia Spoerl
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 87, p 87 (2022)
International Journal of Molecular Sciences; Volume 23; Issue 1; Pages: 87
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 23; Issue 1; Pages: 87
International Journal of Molecular Sciences
Oral cancer often presents with aggressive behavior and a high risk of recurrence and metastasis. For oral squamous cell carcinoma (OSCC), which is the most frequent histological subtype, therapy strategies include surgery, radiation therapy, chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af68985dd79f929b683a35a5e33b64ad
https://www.mdpi.com/1422-0067/23/1/87
https://www.mdpi.com/1422-0067/23/1/87